A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) - Mateo, J; Chakravarty, D; Dienstmann, R; Jezdic, S; Gonzalez-Perez, A; Lopez-Bigas, N; Ng, CK Y; Bedard, P L; Tortora, G; Douillard, J Y; Van Allen, E M; Schultz, N; Swanton, C; André, F; Pusztai, L (Ann Oncol, 2018)